Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Parents

Related Issuers

IPTs: Clariane SE €500m Long 5NC2 Sr Unsec; 7-7.25%

HYC European Market: Deal Flow - General

Issuer

Term

Call

Maturity

Size

Ranking

Type

ISIN

IPT

Clariane SE

Long 5NC2

2

Mar-32

€500m

Sr Unsec

Fixed

XS3491326727

7-7.25%


IPTs: Long 5NC2: 7-7.25%


  • Issuer: Clariane SE
  • Business: Europe's leading care service provider with activities in non-acute care, healthy aging and dependency prevention
  • UOP: Together with cash on balance sheet, to refinance €350m term loan and €150m real estate term loan, and pay fees and expenses
  • Corporate Ratings (M/S): B2 (Stable) / B+ (Stable)
  • Expected Issue Ratings (M/S): B2 / B+
  • Currency: EUR
  • Offering Size: €500,000,000
  • Instrument: Senior Unsecured Notes
  • Tenor: Long 5 Years (Mar-32)
  • Call Protection: NC2 (50%, 25%, Par)
  • Change of Control: Put @ 101
  • Distribution: Reg S
  • ISIN: XS3491326727
  • Day Count: 30/360
  • Denominations: €100k x €1k
  • Listing: Euronext Dublin
  • Governing Law: New York Law
  • Joint Global Coordinators and Physical Bookrunners: BNP Paribas (B&D), CACIB, SG
  • Joint Global Coordinators and Joint Bookrunners: CIC, Natixis
  • Joint Bookrunners: GS, JPM, KBC, LBP, MS, UCI
  • Advertisement: This communication is an advertisement and does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129 or the Prospectus Rules: Admission to Trading on a Regulated Market sourcebook. The Offering Memorandum, when published, will be available on the website of the Euronext website https://live.euronext.com
  • Target Market: No EU PRIIPs key information document (KID) and no UK disclosure document required by DISC have been prepared as the notes are not available to retail in EEA or UK
  • Timing:
    • Tomorrow's business
    • GIC 07-Sep-26 @ 11:00 UKT / 12:00 CET
    • 1-on-1's 07-Sep-26 - 08-Sep-26
  • Roadshow:
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.